In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis

Djamel Lebeche, Roger Kaprielian, Federica Del Monte, Gordon F. Tomaselli, Judith K. Gwathmey, Arnold Schwartz, Roger J. Hajjar

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background - Prolongation of the action potential duration (APD) and decreased transient outward K+ current (Ito] have been consistently observed in cardiac hypertrophy. The relation between electrical remodeling and cardiac hypertrophy in vivo is unknown. Methods and Results - We studied rat hearts subjected to pressure overload by surgical ascending aortic stenosis (AS) and simultaneously infected these hearts with an adenovirus carrying either the Kv4.3 gene (Ad.Kv4.3) or the β-galactosidase gene (Ad.β-gal). Ito density was reduced and APD50 was prolonged (P<0.05) in AS rats compared with sham rats. Kv4.2 and Kv4.3 expressions were decreased by 58% and 51%, respectively (P<0.05). AS rats infected with Ad.β-gal developed cardiac hypertrophy compared with sham rats, as assessed by cellular capacitance and heart weight-body weight ratio. Associated with the development of cardiac hypertrophy, the expression of calcineurin and its downstream transcription factor nuclear factor of activated T cells (NFAT) c1 was persistently increased by 47% and 36%, respectively (P<0.05) in AS myocytes infected with Ad.β-gal compared with sham myocytes. In vivo gene transfer of Kv4.3 in AS rats was shown to increase Kv4.3 expression, increase Ito density, and shorten APD50 by 1.6-fold, 5.3-fold, and 3.6-fold, respectively (P<0.05). Furthermore, AS rats infected with Ad.Kv4.3 showed significant reductions in calcineurin and NFAT expression. (P<0.05). Conclusions - Downregulation of Ito, APD prolongation, and cardiac hypertrophy occur early after AS, and in vivo gene transfer of Kv4.3 can restore these electrical parameters and abrogate the hypertrophic response via the calcineurin pathway.

Original languageEnglish (US)
Pages (from-to)3435-3443
Number of pages9
JournalCirculation
Volume110
Issue number22
DOIs
StatePublished - Nov 30 2004
Externally publishedYes

Fingerprint

Aortic Valve Stenosis
Cardiomegaly
Calcineurin
Genes
NFATC Transcription Factors
Muscle Cells
Action Potentials
Galactosidases
Atrial Remodeling
Adenoviridae
Transcription Factors
Down-Regulation
Body Weight
Pressure
Weights and Measures

Keywords

  • Gene therapy
  • Hypertrophy
  • Ion channels
  • Potassium
  • Stenosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Lebeche, D., Kaprielian, R., Del Monte, F., Tomaselli, G. F., Gwathmey, J. K., Schwartz, A., & Hajjar, R. J. (2004). In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation, 110(22), 3435-3443. https://doi.org/10.1161/01.CIR.0000148176.33730.3F

In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. / Lebeche, Djamel; Kaprielian, Roger; Del Monte, Federica; Tomaselli, Gordon F.; Gwathmey, Judith K.; Schwartz, Arnold; Hajjar, Roger J.

In: Circulation, Vol. 110, No. 22, 30.11.2004, p. 3435-3443.

Research output: Contribution to journalArticle

Lebeche, D, Kaprielian, R, Del Monte, F, Tomaselli, GF, Gwathmey, JK, Schwartz, A & Hajjar, RJ 2004, 'In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis', Circulation, vol. 110, no. 22, pp. 3435-3443. https://doi.org/10.1161/01.CIR.0000148176.33730.3F
Lebeche, Djamel ; Kaprielian, Roger ; Del Monte, Federica ; Tomaselli, Gordon F. ; Gwathmey, Judith K. ; Schwartz, Arnold ; Hajjar, Roger J. / In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. In: Circulation. 2004 ; Vol. 110, No. 22. pp. 3435-3443.
@article{85acbd79835443ed9e42c031a44ef253,
title = "In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis",
abstract = "Background - Prolongation of the action potential duration (APD) and decreased transient outward K+ current (Ito] have been consistently observed in cardiac hypertrophy. The relation between electrical remodeling and cardiac hypertrophy in vivo is unknown. Methods and Results - We studied rat hearts subjected to pressure overload by surgical ascending aortic stenosis (AS) and simultaneously infected these hearts with an adenovirus carrying either the Kv4.3 gene (Ad.Kv4.3) or the β-galactosidase gene (Ad.β-gal). Ito density was reduced and APD50 was prolonged (P<0.05) in AS rats compared with sham rats. Kv4.2 and Kv4.3 expressions were decreased by 58{\%} and 51{\%}, respectively (P<0.05). AS rats infected with Ad.β-gal developed cardiac hypertrophy compared with sham rats, as assessed by cellular capacitance and heart weight-body weight ratio. Associated with the development of cardiac hypertrophy, the expression of calcineurin and its downstream transcription factor nuclear factor of activated T cells (NFAT) c1 was persistently increased by 47{\%} and 36{\%}, respectively (P<0.05) in AS myocytes infected with Ad.β-gal compared with sham myocytes. In vivo gene transfer of Kv4.3 in AS rats was shown to increase Kv4.3 expression, increase Ito density, and shorten APD50 by 1.6-fold, 5.3-fold, and 3.6-fold, respectively (P<0.05). Furthermore, AS rats infected with Ad.Kv4.3 showed significant reductions in calcineurin and NFAT expression. (P<0.05). Conclusions - Downregulation of Ito, APD prolongation, and cardiac hypertrophy occur early after AS, and in vivo gene transfer of Kv4.3 can restore these electrical parameters and abrogate the hypertrophic response via the calcineurin pathway.",
keywords = "Gene therapy, Hypertrophy, Ion channels, Potassium, Stenosis",
author = "Djamel Lebeche and Roger Kaprielian and {Del Monte}, Federica and Tomaselli, {Gordon F.} and Gwathmey, {Judith K.} and Arnold Schwartz and Hajjar, {Roger J.}",
year = "2004",
month = "11",
day = "30",
doi = "10.1161/01.CIR.0000148176.33730.3F",
language = "English (US)",
volume = "110",
pages = "3435--3443",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "22",

}

TY - JOUR

T1 - In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis

AU - Lebeche, Djamel

AU - Kaprielian, Roger

AU - Del Monte, Federica

AU - Tomaselli, Gordon F.

AU - Gwathmey, Judith K.

AU - Schwartz, Arnold

AU - Hajjar, Roger J.

PY - 2004/11/30

Y1 - 2004/11/30

N2 - Background - Prolongation of the action potential duration (APD) and decreased transient outward K+ current (Ito] have been consistently observed in cardiac hypertrophy. The relation between electrical remodeling and cardiac hypertrophy in vivo is unknown. Methods and Results - We studied rat hearts subjected to pressure overload by surgical ascending aortic stenosis (AS) and simultaneously infected these hearts with an adenovirus carrying either the Kv4.3 gene (Ad.Kv4.3) or the β-galactosidase gene (Ad.β-gal). Ito density was reduced and APD50 was prolonged (P<0.05) in AS rats compared with sham rats. Kv4.2 and Kv4.3 expressions were decreased by 58% and 51%, respectively (P<0.05). AS rats infected with Ad.β-gal developed cardiac hypertrophy compared with sham rats, as assessed by cellular capacitance and heart weight-body weight ratio. Associated with the development of cardiac hypertrophy, the expression of calcineurin and its downstream transcription factor nuclear factor of activated T cells (NFAT) c1 was persistently increased by 47% and 36%, respectively (P<0.05) in AS myocytes infected with Ad.β-gal compared with sham myocytes. In vivo gene transfer of Kv4.3 in AS rats was shown to increase Kv4.3 expression, increase Ito density, and shorten APD50 by 1.6-fold, 5.3-fold, and 3.6-fold, respectively (P<0.05). Furthermore, AS rats infected with Ad.Kv4.3 showed significant reductions in calcineurin and NFAT expression. (P<0.05). Conclusions - Downregulation of Ito, APD prolongation, and cardiac hypertrophy occur early after AS, and in vivo gene transfer of Kv4.3 can restore these electrical parameters and abrogate the hypertrophic response via the calcineurin pathway.

AB - Background - Prolongation of the action potential duration (APD) and decreased transient outward K+ current (Ito] have been consistently observed in cardiac hypertrophy. The relation between electrical remodeling and cardiac hypertrophy in vivo is unknown. Methods and Results - We studied rat hearts subjected to pressure overload by surgical ascending aortic stenosis (AS) and simultaneously infected these hearts with an adenovirus carrying either the Kv4.3 gene (Ad.Kv4.3) or the β-galactosidase gene (Ad.β-gal). Ito density was reduced and APD50 was prolonged (P<0.05) in AS rats compared with sham rats. Kv4.2 and Kv4.3 expressions were decreased by 58% and 51%, respectively (P<0.05). AS rats infected with Ad.β-gal developed cardiac hypertrophy compared with sham rats, as assessed by cellular capacitance and heart weight-body weight ratio. Associated with the development of cardiac hypertrophy, the expression of calcineurin and its downstream transcription factor nuclear factor of activated T cells (NFAT) c1 was persistently increased by 47% and 36%, respectively (P<0.05) in AS myocytes infected with Ad.β-gal compared with sham myocytes. In vivo gene transfer of Kv4.3 in AS rats was shown to increase Kv4.3 expression, increase Ito density, and shorten APD50 by 1.6-fold, 5.3-fold, and 3.6-fold, respectively (P<0.05). Furthermore, AS rats infected with Ad.Kv4.3 showed significant reductions in calcineurin and NFAT expression. (P<0.05). Conclusions - Downregulation of Ito, APD prolongation, and cardiac hypertrophy occur early after AS, and in vivo gene transfer of Kv4.3 can restore these electrical parameters and abrogate the hypertrophic response via the calcineurin pathway.

KW - Gene therapy

KW - Hypertrophy

KW - Ion channels

KW - Potassium

KW - Stenosis

UR - http://www.scopus.com/inward/record.url?scp=10044227180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044227180&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000148176.33730.3F

DO - 10.1161/01.CIR.0000148176.33730.3F

M3 - Article

VL - 110

SP - 3435

EP - 3443

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 22

ER -